Pharma Research Shares Rise 4.89%... Company Hosts '7th Global Symposium' Bringing Together 750 Medical Professionals from 64 Countries
Pharma Research shares rose more than 4%, drawing attention to the company's academic exchange activities targeting global medical professionals. However, no direct causal relationship has been confirmed between the hosting of the symposium and the stock price increase. **Stock Price Trend... Disti

Pharma Research shares rose more than 4%, drawing attention to the company's academic exchange activities targeting global medical professionals. However, no direct causal relationship has been confirmed between the hosting of the symposium and the stock price increase.
Stock Price Trend... Distinction Needed Between Displayed Price and Regular Session Closing Price
The displayed share price of Pharma Research (214450) was 236,000 won, up 11,000 won (4.89%) from the previous trading day. Separately, the regular session closing price was 234,500 won, up 9,500 won. The two prices are based on different trading references and must be distinguished.
Some 750 Medical Professionals from 64 Countries Attend... '7th PGS' Held in Gangneung
Pharma Research announced on the 2nd that it held the '7th Pharma Research Global Symposium (PGS)' in Gangneung, Gangwon Province, from the 26th to the 28th of last month. According to the company, around 750 medical professionals in the fields of aesthetics and regenerative medicine from 64 countries, including the United States, Australia, Thailand, Japan, and Indonesia, attended the event.
PGS is an event organized to share research achievements and clinical experience in regenerative medicine and the PDRN and PN fields. This year, clinical application cases and procedure trends of the company's proprietary DOT-based PN and PDRN were covered.
The event consisted of an R&D tour of production facilities and an academic symposium. Participants examined the raw material extraction and processing procedures using domestically farmed salmon at the Korea Fisheries Resources Agency's East Sea Life Resources Center. They then toured raw material processing, product production, and quality control processes at Pharma Research's Gangneung plant.
Academic Symposium Held in 4 Sessions... Presentations from the US, Thailand, Australia, and Others
The academic symposium was conducted in four sessions covering the scientific understanding and treatment strategies of Rejuran, safety and the latest clinical research, various clinical application possibilities, and enhancing treatment experience.
Dr. Suneel Chilukuri of the United States introduced the safety profile of Rejuran PN. Thai medical professionals presented PN-related research and clinical cases from various body areas, while Dr. Steven Liew of Australia addressed skin regeneration mechanisms centered on histological evidence. Medical professionals from Indonesia and Japan shared application cases for the lip area and combined procedure experiences, respectively.
However, the clinical experiences and research presentations introduced at the event do not imply approval or confirmed efficacy for all application areas. The design and results of individual studies, as well as country-specific approval scopes, need to be verified separately.
Actress Kim Se-jeong, global ambassador for Rejuran and Rejuran Cosmetic, also attended the event. The company stated that it will continue to expand academic exchanges with medical professionals at home and abroad.
Future Points to Watch... Market Trends on the 9th and Link to Overseas Sales
In the stock market on Monday the 9th, whether Pharma Research's upward trend continues and whether buying pressure accompanied by trading volume is sustained will be key observations. Although the displayed price is higher than the regular session closing price, the trading market and time have not been confirmed, making it difficult to use this as grounds for an increase on the next trading day.
On the business side, it remains to be confirmed whether the expanded contact with global medical professionals translates into actual product demand and overseas sales. The number of participating countries and attendees alone cannot be taken as conclusive evidence of new market entry or earnings growth.
[This article received some assistance from AI in its writing process. It does not recommend buying or selling any specific stock, and investment decisions and responsibilities rest with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Cyberattack via Optimizely Exposes 178 Global Organizations... CNN, BBC, HSBC, and Ledger Also Affected](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F627874%2Ffc472b72a2596aa1%2Fvariants%2Fhero.webp&w=1920&q=75)


